Overview
The goal of this clinical trial is to evaluate how different approaches to executive function (like adding game-like features, varying the number of tasks, and providing coaching) can enhance executive function outcomes in adolescents with and without ADHD. The main questions it aims to answer are:
- What components of executive function training contribute most to improving outcomes?
- How do training components vary in their impacts on adolescents diagnosed with ADHD compared to those without a diagnosis?
- What individual characteristics influence the effectiveness of executive function training?
Researchers will test six different training setups to examine which setups are the most effective for different people. They will evaluate both how well participants follow the training schedule and whether there are changes in psychological and cognitive outcomes after training.
Participants will complete:
- 40 training sessions over 4 weeks
- A set of tests and surveys before and after the training
- Follow-up assessments and surveys 6 months after finishing the training
Eligibility
Inclusion Criteria:
- 12-17 years old.
- Child must have a caregiver (parent/guardian) who is available to participate as a training aide.
- Child and parent/caregiver are able to understand/speak adequate English or Spanish to follow and participate in study procedures
- Both child and parent/guardian are willing to give informed consent/assent, be randomized to either intervention condition, and be willing to follow the assigned study protocol.
- \~50% of the participants: Meet criteria for ADHD DSM-5 diagnosis.
Exclusion Criteria:
- Child is taking ADHD medication/stimulants.
- Child has been formally identified as intellectually disabled.
- Abnormal visual acuity or hearing challenges that are prohibitive to participating in the intervention/assessment.
- History of organic mental disorders (conditions or disturbances that may be caused by injuries and/or neurodegenerative diseases affecting brain tissues), psychosis, history of autism spectrum disorders, intellectual disability, or active substance use or suicidal ideation (such individuals will be referred to psychiatric services).
- Major sensory or motor impairment that would preclude valid cognitive testing.
- Participants with color blindness, if they are unable to discriminate the task relevant stimuli.
- Populations considered vulnerable such as wards and those with neurological or other health conditions that may prevent the ability to give informed consent.
